| Tamoxifen: a most unlikely pioneering medicine VC Jordan Nature reviews Drug discovery 2 (3), 205-213, 2003 | 2650 | 2003 |
| The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial SR Cummings, S Eckert, KA Krueger, D Grady, TJ Powles, JA Cauley, ... Jama 281 (23), 2189-2197, 1999 | 2580 | 1999 |
| Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial VG Vogel, JP Costantino, DL Wickerham, WM Cronin, RS Cecchini, ... Jama 295 (23), 2727-2741, 2006 | 2132 | 2006 |
| Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer RR Love, RB Mazess, HS Barden, S Epstein, PA Newcomb, VC Jordan, ... New England journal of medicine 326 (13), 852-856, 1992 | 1462 | 1992 |
| The pharmacology and clinical uses of tamoxifen BJA Furr, VC Jordan Pharmacology & therapeutics 25 (2), 127-205, 1984 | 1168 | 1984 |
| Basic guide to the mechanisms of antiestrogen action JI Macgregor, VC Jordan Pharmacological reviews 50 (2), 151-196, 1998 | 1032 | 1998 |
| Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial JA Cauley, L Norton, ME Lippman, S Eckert, KA Krueger, DW Purdie, ... Breast cancer research and treatment 65, 125-134, 2001 | 973 | 2001 |
| International union of pharmacology. LXIV. Estrogen receptors K Dahlman-Wright, V Cavailles, SA Fuqua, VC Jordan, ... Pharmacological reviews 58 (4), 773-781, 2006 | 842 | 2006 |
| Update of the national surgical adjuvant breast and bowel project study of tamoxifen and raloxifene (STAR) P-2 trial: preventing breast cancer VG Vogel, JP Costantino, DL Wickerham, WM Cronin, RS Cecchini, ... Cancer prevention research 3 (6), 696-706, 2010 | 776 | 2010 |
| MCF-7: the first hormone-responsive breast cancer cell line AS Levenson, VC Jordan Cancer research 57, 3071-3078, 1997 | 698 | 1997 |
| A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity VC Jordan, MM COLLINS, L ROWSBY, G Prestwich Journal of Endocrinology 75 (2), 305-316, 1977 | 649 | 1977 |
| The estrogen receptor: a model for molecular medicine EV Jensen, VC Jordan Clinical cancer research 9 (6), 1980-1989, 2003 | 630 | 2003 |
| Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture LJ Lerner, VC Jordan Cancer research 50 (14), 4177-4189, 1990 | 603 | 1990 |
| Biochemical pharmacology of antiestrogen action. VC Jordan Pharmacological Reviews 36 (4), 245-276, 1984 | 586 | 1984 |
| Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse MM Gottardis, SP Robinson, PG Satyaswaroop, VC Jordan Cancer research 48 (4), 812-815, 1988 | 575 | 1988 |
| Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration MM Gottardis, VC Jordan Cancer Research 48 (18), 5183-5187, 1988 | 549 | 1988 |
| Most plastic products release estrogenic chemicals: a potential health problem that can be solved CZ Yang, SI Yaniger, VC Jordan, DJ Klein, GD Bittner Environmental health perspectives 119 (7), 989-996, 2011 | 535 | 2011 |
| Endocrine pharmacology of antiestrogens as antitumor agents VC Jordan, CS Murphy Endocrine reviews 11 (4), 578-610, 1990 | 530 | 1990 |
| Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomata VC Jordan European Journal of Cancer (1965) 12 (6), 419-424, 1976 | 528 | 1976 |
| Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents VC Jordan Journal of medicinal chemistry 46 (7), 1081-1111, 2003 | 521 | 2003 |
